Neoxpert Expanded Screening Panel Test (Newborn Screening 48+ Analytes)

Parents who have previously had healthy babies or have no family history of any disorder of such type may still have babies born with these disorders. In most cases, the babies born with the disorder appear to be totally healthy. With the new-born screening test, your doctor can find a problem with your baby before it causes any major concern.

Babies with haemoglobinopathies, metabolic disorders and hereditary disorders can nonetheless be born to parents who have earlier had healthy pregnancies or who have no family background of the non-hereditary disorders. Usually, infants born with the disease show no symptoms early on. Therefore, it becomes imperative for your doctor to perform a comprehensive screening such as the Neoxpert Expanded Screening Panel test to detect disorders, if any, in your newborn child.

Newborn screening test includes CF, TSH, G6PD, 17-OHP, Total galactose, MSUD, PKU, Biotinidase, 13 disorders of amino acid metabolism & 27  acyl acrnitine disorders which includes organic acidurias & fatty acid metabolism disorders.

1 drop of heel prick or finger prick blood on special filter paper DBS card

A drop of blood is extracted from the baby through a finger or heel prick, placed on a card made of special filter paper, and sent for testing. The heel may have mild bruising and redness at the site of the prick, but gets better in a few days.

As per high or low values of primary biomarkers e.g (High Tyrosine in  tyrosinemia disorder), disorders are divided into different categories as follow:
Disorders of protein metabolism e.g. defects in Amino Acids
Disorders of carbohydrate metabolism
Disorders of fatty acid oxidation
Disorders of organic acids
Lysosomal storage disorders
Mitochondrial storage disorders
Peroxisomal disorders

Disorders are categorized according to low or high values of primary biomarkers screened for. Results may be read as in-range, out-of-range, and borderline. Out-of-range or abnormal values of these biomarkers may indicate the following conditions:

• Protein metabolism issues like amino acid deficiencies
• Disorders of carbohydrate metabolism
• Fatty acid oxidation disorders
• Problems with organic acids
• Lysosomal storage disorders
• Mitochondrial storage disorders
• Disorders of the peroxisome

Babies and newborns are subject to newborn screening to look for any potential fetal issues. Your doctor can identify a problem with your baby with the newborn screening test to offer prompt treatment.

Within 24 to 48 hours of the baby's birth, this test is conducted. It helps with the early detection of various genetic disorders that may lead to serious problems with a baby's development.

No. The test is carried out in newborn babies within 24 to 48 hours of birth.

Several parameters are tested for and each one has its own set of ranges. Consult your doctor or our customer care team for more information

This is a comprehensive test for newborn screening. Based on the results of this test, your doctor may prescribe further testing.

• Newborn Screening (NBS)

Newborn babies may be afflicted by a variety of conditions including cystic fibrosis, hereditary disorders, haemoglobinopathies, and inherited metabolic disorders (IMDs) from birth. IMDs are brought on by a gene abnormality that causes an enzyme deficit. Therefore, screening is crucial to identify potential fetal problems in newborns as quickly as possible, well before they show any symptoms of the disorder. Early diagnosis enables prompt treatment, which lessens the condition's negative effects. Newborn screening offers one such comprehensive screening method.

The Newborn screening is done on infants and newborn babies to check for potential fetal problems. Usually, this test is performed 24 to 48 hours after the infant is born. It aids in the detection of some genetic diseases that could cause a baby to experience severe issues during infancy and development